◆ 会议时间：2026年4月10-13日
◆ 会议地点：美国 圣胡安

◆ 会议简介：

2026年第57届美国妇科肿瘤学会(SGO)妇科肿瘤年会(妇女癌症年会)将于2026年4月10-13日在美国圣胡安举行，会议由美国妇科肿瘤学会(SGO)主办。妇科肿瘤学会(SGO)女性癌症年会汇集了妇科肿瘤学专业最优秀、最杰出的妇科肿瘤学专家，一起学习和分享有关妇科恶性肿瘤治疗的最新研究和实践创新，为期4天的会议将提供各种教学和互动形式的教育课程，可以使与会者始终处于该领域的最前沿，为患者提供最佳的循证护理。

SGO妇科肿瘤会议是妇女保健专业人员的首要教育和科学活动，包括在化疗、放射治疗、外科和姑息治疗领域提供治疗和护理的妇科癌症护理团队的成员。与会者包括妇科肿瘤专家、肿瘤科医生、病理学家、放射肿瘤学家、血液科医生、外科肿瘤学家、妇产科医生、药剂师、护士、执业护士、助理医师、研究科学家、培训研究员、住院医师和社会工作者(领域国际医学会议网)，上届SGO年会有2500余名代表出席。

美国妇科肿瘤学会(SGO)是全球首屈一指的专业致力于妇科肿瘤的研究、治疗与教育的非营利性医学组织。SGO前身为1968年成立的妇科肿瘤学家学会(SGO)-Society of Gynecologic Oncologists，2011年更为现名妇科肿瘤学会(SGO)-Society of Gynecologic Oncology。SGO的使命是通过倡导、教育、研究和跨学科合作，为宣提高妇女癌症的护理水平作出贡献。目前SGO在全球拥有超2000名成员，主要包括妇科肿瘤学家、肿瘤内科学家、医师助理，病理学家、放射肿瘤学家，血液学家，外科肿瘤学家，产科医生/妇科医生，护士及其他对妇女癌症治疗和护理感兴趣的相关人士(未经本站允许，禁止复制摘录转载本站任何内容-领域国际医学会议网(lingyuint.com)

SGO 2026 - Society of Gynecologic Oncology (SGO) Annual Meeting on Women's Cancer

Date:
April 10-13, 2026

Venue:
San Juan, PR, USA

The SGO Annual Meeting on Women’s Cancer® is the premier educational and scientific event for those who treat and care for individuals with gynecologic cancer.

Since 1969, gynecologic oncology professionals have convened at the Society of Gynecologic Oncology (SGO)’s Annual Meeting on Women’s Cancer to discuss the latest science in the field, receive educational programming, and to network.

Members of the entire gynecologic cancer care team who provide treatment and care in the areas of chemotherapy, radiation therapy, surgery, and palliative care attend the SGO Annual Meeting. Gynecologic oncologists make up a large population of the attendees, along with medical oncologists, pathologists, radiation oncologists, hematologists, surgical oncologists, obstetrician/gynecologists, nurses, physician assistants, fellows in training, residents, and pharmacists.

The SGO Annual Meeting also brings together exhibitors from a variety of medical device and service companies. An array of state-of-the-art products and services geared towards members of the gynecologic cancer care team are on display in the exhibition area. There are numerous sponsorship opportunities as well for various events, services and takeaway items at the SGO Annual Meeting on Women’s Cancer.

摘要征文投稿：

Submit Abstracts and Surgical Films

Submissions are due September 26, 2025

SGO is now accepting abstract and surgical film submissions for presentation consideration at the SGO 2026 Annual Meeting on Women’s Cancer. New this year: late-breaking abstract submissions are also open! All submissions, including late-breaking abstracts, are due September 26, 2025, at 11:59 p.m. CT.

提交>>>Submit Abstracts and surgical films

点此查看更多摘要提交相关信息>>>

Advancing Science. Empowering Teams. Embracing Change.

1. Clinical Trials/Novel Therapeutics

2. Innovative Surgery

3. Disparities & Population Health

4. Translational Science & Biomarkers

5. Patient Consideration & Survivorship

6. Prevention & Genetics

Submission Types

• Abstract: Innovative science covering a range of topics that are relevant to gynecologic oncology 
• Trials in Progress Poster (TIPs): Typically slotted as a poster this includes ongoing research initiated and conducted with data/results not available
• Surgical Film: Documents a surgical procedure, serves as an instructional tool  
• Late-Breaking Abstract: Ground-breaking, high-impact science – Don’t miss the change to the submission process this year

Abstracts, Trials in Progress Posters, and Surgical Films: 

Submission Eligibility 

• Submissions may address any topic relevant to SGO’s mission. Key Concepts facilitate the peer-review process and are not meant to limit research submitted for consideration. 
• Submissions must be new, impactful science that has not been presented or published before the SGO Annual Meeting, April 10-13, 2026. Research that is ongoing or previously presented can only be submitted if significant developments can be shown. These encore presentations are selected at the discretion of the SGO Annual Meeting Program Committee. 
• SGO is not responsible for registration expenses and other travel accommodations. 
• Fees, sponsorship, and/or SGO membership are not required to submit an abstract. 
• SGO reserves the right to decline abstracts or withdraw presentations if deemed necessary. 

Submission Requirements 

• SGO reserves the right to use a medical editor to check for errors and make minor updates.  
• Each Abstract Submission must clearly identify the following:  
  • Title: Describe the nature of the content but does not include author or affiliation identifying terms. Use sentence case and capitalize only the first word and proper nouns.
  • Objectives: An introductory sentence indicating the purpose of the study  
  • Methods: A brief description of pertinent experimental procedures, including statistics 
  • Results: A summary of the new, unpublished data 
  • Conclusions: A statement of the conclusions 
• Character Limit: 3,000 characters, including spaces; this does not include abstract title, author string, nor a single allotted table or graph.  
• Institution Names and Location: Abstract text must be anonymous for grading purposes. Do not reference institution names or locations in the body of your abstract. 
• No Use of Brand Names and Trade Names in Submissions: Brand names of pharmaceuticals and trade names of medical devices cannot be used in the title or body of the abstract.  
• Table/Graph: Each abstract submission is limited to one (1) table or graph. Do not enter charts, graphs, bullet points, indentations, or references in the abstract text.  
• Language Format and Grammar: Text must be in English or British format only. Review your abstract for grammar and spelling errors prior to submitting. 
• Artificial Intelligence (AI): Abstracts should not be authored by generative artificial intelligence (AI) in the writing process but rather used to improve grammar and readability. 
• Surgical Film Submissions: 
  • Evaluated based on educational content and audio/visual quality.  
  • Submit with sound, at regular speed, in .AVI, .MOV, or .MP4 formats (.MP4 files preferred)
  • The maximum file size is 200 MB. A PowerPoint presentation is not required.
  • Under 10 minutes long
  • Free from commercial/product bias and logos.  

Review Scoring Criteria

Submissions are peer-reviewed for scientific merit, quality, advanced, and innovative methods.

Presenting Author Requirement and Acceptance Notifications 

• Submission Categories: A submission may be submitted using the Submitter Only, Presenting Author, or Author categories; only one Presenting Author can be indicated and will be listed first.
• Multiple Abstracts and Surgical Films: A presenting author may submit multiple abstracts; however, presentations cannot occur at the same time, unless designated as on-demand or virtual. 
  • Use the same contact information for each abstract if submitting more than one abstract.  
  • Individual authors cannot submit the same abstract or surgical film. 

• Authorship: The author limit is 25. If your abstract exceeds this, email education@sgo.org. Author names and institutions should be written in full, with the primary degree for each author (ex: MD, PhD). Each author must provide a city or province, state, and country when completing the SGO Bio form. 
• Responsibilities: All submission categories are responsible for sending bio and disclosure invitations to co-authors and arranging the author list in the desired order for publication in the final online abstract supplement.  
  • Use the search database function to locate and include each author in the abstract. 
  • Presenters are required to provide disclosure of relationships with commercial interests. 
  • Each author will receive an email with a unique link to complete the SGO Bio and COI Disclosure forms. The abstract submitter may track the authors’ progress of COI Disclosure form completion and send reminder emails using the author list for your abstract. 
  • SGO will also send reminder communications to complete bios and disclosures. 

Steps for Submission 

• Select only one Key Concept Group category that best represents the content of your abstract.  
• Multiple disease sites may be selected. 
• Complete the online submission form, ensuring that each field is completed as instructed. Click the “Save” button or “Next” when you have completed each section.  
• Each author listed on the abstract must complete all required demographic, biographical, and conflict of interest information for the abstract to be eligible for review. 
• Click “Submit for Review” before the published deadline to ensure your abstract is formally submitted. You will receive a confirmation email once the abstract has been successfully submitted.  
• Edits may be made in the online system until the submission deadline, at which point the site will close, and no further changes will be allowed. 
• Contact SGO Education Department at education@sgo.org for questions.  

Acceptance Notifications 

Presenting authors will receive all email communications related to accepted submissions by mid-December 2025, (unless stated otherwise),  and will be required to complete the acceptance survey in order to present at the SGO Annual Meeting. Please note: Poster notifications may be delayed due to batch number assignments. A follow-up email will be sent to presenting authors, providing access to the Speaker Portal to upload PowerPoint presentations and complete all required information. 

Late-Breaking Abstracts

• Must present high-impact research findings that were not available by the regular abstract submission deadline.

• Should include randomized trials or original research with innovative, practice-changing results.

• Cannot be used to extend the general abstract deadline. All studies with complete data should be submitted as a general abstract.

Submission Shell Requirements  

• Title of the abstract: Describe the nature of the content, but do not include author or affiliation identifying terms. Use sentence case and capitalize only the first word and proper nouns.
  • Title Example: Combination of BVAC-C and durvalumab in recurrent or metastatic cervical cancer: a phase II study 
• Author(s) and their affiliation: note that the author list may be updated during the full resubmission process, if the abstract is accepted. The submitter and presenting author should be listed. 
• Objective: a brief explanation of why the abstract qualifies as late-breaking 

Submissions Must Include 

• Introduction: A brief statement about the purpose of the study and its pertinent background. 
• Method: the method(s) of study or data collection employed.  
• Expected Results: if available, include any preliminary findings or anticipated analyses and data to be reported. 
• Impact: Highlight the potential implications of the study and why it is of high importance to the field. 

Review Criteria 

• • Submissions will be peer-reviewed and evaluated based on: 
    • Scientific merit and originality 
    • Significance to the field 
    • Clarity of data and conclusions 

Late-Breaking Abstract Timeline 

• Monday, July 21, 2025 – Abstract Submission Opens 
• Friday, September 26, 2025 – Abstract Submission Deadline 
• Early November 2025 – Late-breaking Abstract Shell Selection Notifications 
• Mid-November 2025 – Complete Late-breaking Abstract Shell Selection Survey   
• Monday, January 19, 2026 – Upload Final LBA Submission Details 
• Early February 2026 – Notifications of Acceptance for Final Round of LBAs 
• Mid-February 2026 – Complete LBA Required Presentation Acceptance Survey 
• Thursday, February 12, 2025 – After Abstract Acceptance: Withdraw or Reassign Another Presenting Author 
• Wednesday, February 18, 2026 – Presenting Authors Complete Disclosures and Register for the Meeting  
• Tuesday, March 3, 2026 – Upload PowerPoint Presentation (using the official SGO template) and Complete all Required Tasks in the Speaker Portal. 

Additional Information  

• An author may submit more than one late-breaking abstract 
• Shell submissions that do not meet the criteria will not be reviewed 

Important: To ensure a fair review process, authors must submit a late-breaking abstract shell by the deadline, Friday, September 26, 2025 at 11:59 p.m. CT.

Submit late-breaking abstract shells